<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><title>RTT - Momentum</title><link>http://www.rttnews.com</link><description>Global financial news, market analysis, economics and forex news</description><language>en-us</language><lastBuildDate>Wed, 16 May 2012 14:15:02 GMT</lastBuildDate><item><title>Rosetta Genomics Ltd. (ROSG) Is Sharply Higher After Reaching Milestone </title><description>Rosetta Genomics Ltd. (ROSG) announced Wednesday morning that Novitas informed the company that it plans to cover the company's miRview metsı assay for all Medicare beneficiaries. MiRview metsı accurately identifies the primary tumor of origin in primary and metastatic cancer.</description><link>http://www.rttnews.com/story.aspx?Id=1887810</link><pubDate>Wed, 16 May 2012 13:48:49 GMT</pubDate></item><item><title>MasterCard Inc. (MA) Has Spiked To The Downside </title><description>MasterCard Inc. (MA) gapped open higher Wednesday morning, but has spiked sharply to the downside in early trade. Shares are now down 2.25 at $412.22.</description><link>http://www.rttnews.com/story.aspx?Id=1887807</link><pubDate>Wed, 16 May 2012 13:43:15 GMT</pubDate></item><item><title>Abercrombie &amp; Fitch (ANF) Has Dropped To A New Low On Q1 Results </title><description>Abercrombie &amp; Fitch (ANF) reported first quarter net income of $0.03 per share Wednesday morning, down sharply from $0.28 per share last year. The consensus estimate was for EPS of $0.02. The company maintained its 2012 EPS forecast of $3.50 to $3.75.</description><link>http://www.rttnews.com/story.aspx?Id=1887800</link><pubDate>Wed, 16 May 2012 13:40:07 GMT</pubDate></item><item><title>J. C. Penney Co. (JCP) Has Plunged To A 7-Month Low After Q1 Report </title><description>J. C. Penney Co. (JCP) reported a first quarter adjusted net loss of $0.25 per share after the bell Tuesday, compared to the profit of $0.36 last year. The consensus estimate was for a loss of $0.10. The company also announced that it will discontinue its $0.20 per share quarterly dividend. </description><link>http://www.rttnews.com/story.aspx?Id=1887795</link><pubDate>Wed, 16 May 2012 13:36:24 GMT</pubDate></item><item><title>SINA Corp. (SINA) Is Rising After Narrower Than Expected Q1 Loss </title><description>SINA Corp. (SINA) reported a first quarter non-GAAP net loss of $0.21 per share after the bell Tuesday, compared to the profit of $0.25 per share in the previous year. The consensus estimate was for a loss of $0.23.</description><link>http://www.rttnews.com/story.aspx?Id=1887792</link><pubDate>Wed, 16 May 2012 13:34:20 GMT</pubDate></item><item><title>TJX Companies Inc. (TJX) Is Challenging The Highs After Q1 Report </title><description>TJX Companies Inc. (TJX) reported first quarter adjusted EPS of $0.55 Tuesday morning, up from $0.39 in the previous year. The consensus estimate was for EPS of $0.54. Second quarter EPS is expected to be between $0.47 and $0.50, compared to the consensus estimate of $0.51.</description><link>http://www.rttnews.com/story.aspx?Id=1886537</link><pubDate>Tue, 15 May 2012 13:54:52 GMT</pubDate></item><item><title>OPNET Technologies Inc. (OPNT) Is Up Sharply On Q4 Results </title><description>OPNET Technologies Inc. (OPNT) reported fourth quarter adjusted EPS of $0.21 after the close Monday, compared to $0.20 in the previous year. The consensus estimate was for EPS of $0.21. First quarter adjusted EPS is expected to be between $0.16 and $0.23, compared to the consensus estimate of $0.21.</description><link>http://www.rttnews.com/story.aspx?Id=1886530</link><pubDate>Tue, 15 May 2012 13:43:08 GMT</pubDate></item><item><title>American Science &amp; Engineering (ASEI) Is Sinking After Q4 Report </title><description>American Science &amp; Engineering (ASEI) reported fourth quarter EPS of $0.15 after the bell Monday, down from $1.03 in the prior year period. The Company also announced that its Board of Directors has authorized a $35 million stock repurchase program.</description><link>http://www.rttnews.com/story.aspx?Id=1886527</link><pubDate>Tue, 15 May 2012 13:39:42 GMT</pubDate></item><item><title>Live Nation Entertainment (LYV) Is Adding To Recent Gains </title><description>Live Nation Entertainment (LYV) has been gaining ground since the open of trade Friday. The stock is now up 0.68 at $9.73.</description><link>http://www.rttnews.com/story.aspx?Id=1883834</link><pubDate>Fri, 11 May 2012 14:20:08 GMT</pubDate></item><item><title>McDermott International (MDR) Is Gaining Ground On Q1 Results </title><description>McDermott International (MDR) reported first quarter net income of $0.26 per share after the close Thursday, down from $0.30 per share in the previous year. The consensus estimate was for EPS of $0.15.</description><link>http://www.rttnews.com/story.aspx?Id=1883819</link><pubDate>Fri, 11 May 2012 13:54:16 GMT</pubDate></item><item><title>Dillard's Inc. (DDS) Has Climbed To A New High On Q1 Results </title><description>Dillard's Inc. (DDS) reported first quarter net income of $1.89 per share after the close Thursday, up from $1.31 per share in the prior year period. The consensus estimate was for EPS of $1.67. </description><link>http://www.rttnews.com/story.aspx?Id=1883810</link><pubDate>Fri, 11 May 2012 13:40:40 GMT</pubDate></item><item><title>JPMorgan Chase &amp; Co. (JPM) Has Dropped To Nearly A 3-Month Low </title><description>JPMorgan Chase &amp; Co. (JPM) announced after the close Thursday that since March 31, 2012, its Chief Investment Office has had hefty mark-to-market losses in its synthetic credit portfolio that has proved to be more riskier than expected. JPMorgan said it now estimates its Corporate business, within the Corporate/Private Equity segment, to incur a net loss of about $800 million, which excludes Private Equity results and litigation expense. </description><link>http://www.rttnews.com/story.aspx?Id=1883807</link><pubDate>Fri, 11 May 2012 13:37:46 GMT</pubDate></item><item><title>Arena Pharmaceuticals Inc. (ARNA) Has Surged To A New High After FDA Vote </title><description>Arena Pharmaceuticals Inc. (ARNA) announced after the bell Thursday that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 18 to 4 that the potential benefits of lorcaserin outweigh the potential risks when used long-term in a population of overweight and obese individuals. </description><link>http://www.rttnews.com/story.aspx?Id=1883804</link><pubDate>Fri, 11 May 2012 13:34:14 GMT</pubDate></item><item><title>Windstream Corp. (WIN) Has Plunged To A New Low After Q1 Report </title><description>Windstream Corp. (WIN) reported first quarter adjusted EPS of $0.13 Thursday morning, which fell short of the consensus estimate of $0.14. </description><link>http://www.rttnews.com/story.aspx?Id=1882743</link><pubDate>Thu, 10 May 2012 14:25:19 GMT</pubDate></item><item><title>Edwards Lifesciences Corp. (EW) Has Spiked To The Downside </title><description>Edwards Lifesciences Corp. (EW) traded in a range early Thursday morning, but has dropped sharply in the last few minutes on increased volume. The stock is now down 0.75 at $84.70.</description><link>http://www.rttnews.com/story.aspx?Id=1882735</link><pubDate>Thu, 10 May 2012 14:15:53 GMT</pubDate></item><item><title>Feihe International Inc. (ADY) Has Broken Out To A 9-Month High On Q1 News </title><description>Feihe International Inc. (ADY) reported first quarter net income from continuing operations of $0.40 per share Thursday morning, up from $0.23 per share last year. The consensus estimate was for EPS of $0.24.</description><link>http://www.rttnews.com/story.aspx?Id=1882734</link><pubDate>Thu, 10 May 2012 14:06:14 GMT</pubDate></item><item><title>InfoSpace Inc. (INSP) Is Up Sharply On Q1 Results </title><description>InfoSpace Inc. (INSP) reported first quarter adjusted net income of $0.70 per share after the close Wednesday, up from $0.20 per share last year. The company expects to report second quarter adjusted EPS of $0.40 to $0.44.</description><link>http://www.rttnews.com/story.aspx?Id=1882723</link><pubDate>Thu, 10 May 2012 13:56:43 GMT</pubDate></item><item><title>StarTek Inc. (SRT) Has Surged To A 3-Month High After Q1 Report </title><description>StarTek Inc. (SRT) reported a first quarter loss of $0.40 per share Thursday morning, compared to the loss of $0.17 per share in the previous year. The consensus estimate was for a loss of $0.20. </description><link>http://www.rttnews.com/story.aspx?Id=1882719</link><pubDate>Thu, 10 May 2012 13:50:19 GMT</pubDate></item><item><title>Cisco Systems Inc. (CSCO) Has Dropped To Over A 5-Month Low On Weak Outlook </title><description>Cisco Systems Inc. (CSCO) reported third quarter adjusted EPS of $0.48 after the bell Wednesday, up from $0.42 last year. The consensus estimate was for EPS of $0.47. Fourth quarter adjusted EPS is expected to be between $0.44 and $0.46, which is below the consensus estimate of $0.49.</description><link>http://www.rttnews.com/story.aspx?Id=1882712</link><pubDate>Thu, 10 May 2012 13:42:35 GMT</pubDate></item><item><title>Priceline.com Inc. (PCLN) Is Falling After Q1 Report </title><description>Priceline.com Inc. (PCLN) reported first quarter adjusted EPS of $4.28 after the close Wednesday, up from $2.66 in the prior year period. The consensus estimate was for EPS of $3.95. The company expects to report second quarter adjusted EPS of $7.20 to $7.40, compared to the consensus estimate of 7.38.</description><link>http://www.rttnews.com/story.aspx?Id=1882709</link><pubDate>Thu, 10 May 2012 13:38:18 GMT</pubDate></item><item><title>Monster Beverage Corp. (MNST) Is Up Sharply On Q1 Results </title><description>Monster Beverage Corp. (MNST) reported first quarter first quarter net income of $0.41 per share after the bell Wednesday, up from $0.29 per share in the previous year. The consensus estimate was for EPS of $0.38. </description><link>http://www.rttnews.com/story.aspx?Id=1882704</link><pubDate>Thu, 10 May 2012 13:33:53 GMT</pubDate></item><item><title>Vitamin Shoppe Inc. (VSI) Has Broken Out To A New High On Q1 Results </title><description>Vitamin Shoppe Inc. (VSI) reported first quarter EPS of $0.61 Tuesday morning, up from $0.40 in the prior year period. The consensus estimate was for EPS of $0.57. </description><link>http://www.rttnews.com/story.aspx?Id=1880059</link><pubDate>Tue, 08 May 2012 14:03:17 GMT</pubDate></item><item><title>Generac Holdings Inc. (GNRC) Is Up Sharply On Q1 Earnings News </title><description>Generac Holdings Inc. (GNRC) reported first quarter adjusted EPS of $0.96 Tuesday morning, up from $0.25 in the previous year. The consensus estimate was for EPS of $0.71. The Company also announced its plan to execute a recapitalization in which it intends to incur approximately $650 million of additional debt to fund in large part a special cash dividend of up to $10 per share on its outstanding common stock. </description><link>http://www.rttnews.com/story.aspx?Id=1880045</link><pubDate>Tue, 08 May 2012 13:49:57 GMT</pubDate></item><item><title>Dun &amp; Bradstreet Corp. (DNB) Is Sinking To A 5-Month Low After Q1 Report </title><description>Dun &amp; Bradstreet Corp. (DNB) reported first quarter adjusted EPS of $1.35 after the close Monday, up from $1.29 in the previous year. The consensus estimate was for EPS of $1.35. </description><link>http://www.rttnews.com/story.aspx?Id=1880039</link><pubDate>Tue, 08 May 2012 13:44:34 GMT</pubDate></item><item><title>MAKO Surgical Corp. (MAKO) Has Dropped To A 4-Month Low Following Q1 Report </title><description>MAKO Surgical Corp. (MAKO) reported a first quarter net loss of $0.28 per share after the bell Monday, compared to the loss of $0.27 per share last year. The consensus estimate was for a loss of $0.20. MAKO now anticipates selling 52 to 58 RIO systems in 2012, which compares to prior guidance of 56 to 62 RIO system sales.</description><link>http://www.rttnews.com/story.aspx?Id=1880034</link><pubDate>Tue, 08 May 2012 13:37:46 GMT</pubDate></item><item><title>Fossil Inc. (FOSL) Is Sinking On Weak Forecast </title><description>Fossil Inc. (FOSL) reported first quarter net income of $0.93 per share Tuesday morning, up from $0.86 per share in the prior year period. The consensus estimate was for EPS of $0.92. The company expects to report second quarter EPS of $0.77 to $0.79 and between $5.30 and $5.40 for the full year 2012. The consensus estimates are for EPS of $0.94 and $5.56.</description><link>http://www.rttnews.com/story.aspx?Id=1880032</link><pubDate>Tue, 08 May 2012 13:35:43 GMT</pubDate></item><item><title>Insmed Inc. (INSM) Is Up Sharply After FDA Lifts Clinical Hold On Arikace </title><description>Insmed Inc. (INSM) announced Monday morning that the FDA has lifted the clinical hold previously placed on ARIKACE in Cystic Fibrosis patients with Pseudomonas lung infections. </description><link>http://www.rttnews.com/story.aspx?Id=1878966</link><pubDate>Mon, 07 May 2012 13:54:33 GMT</pubDate></item><item><title>PetMed Express Inc. (PETS) Is Sinking After Q4 Report </title><description>PetMed Express Inc. (PETS) reported fourth quarter net income of $0.20 per share Monday morning, compared to $0.19 per share last year. The consensus estimate was for EPS of $0.18. Net sales came in at $55.9 million, compared to $50.9 million in the prior year. The consensus estimate was for revenues of $52.05 million.</description><link>http://www.rttnews.com/story.aspx?Id=1878961</link><pubDate>Mon, 07 May 2012 13:49:51 GMT</pubDate></item><item><title>Cognizant Technology Solutions (CTSH) Is Sinking On Full Year Forecast </title><description>Cognizant Technology Solutions (CTSH) reported first quarter adjusted EPS of $0.86 Monday morning, up from $0.71 in the previous year. The consensus estimate was for EPS of $0.79. The company expects to report second quarter adjusted EPS of $0.87 and full year 2012 adjusted EPS of $3.62. The consensus estimates are for EPS of $0.83 and $3.45. Earlier, the company forecasted full year 2012 adjusted EPS of $3.69.</description><link>http://www.rttnews.com/story.aspx?Id=1878953</link><pubDate>Mon, 07 May 2012 13:42:51 GMT</pubDate></item><item><title>Vertex Pharmaceuticals (VRTX) Is Surging On Phase 2 Study Results </title><description>Vertex Pharmaceuticals (VRTX) announced Monday morning that an interim analysis of data from an ongoing Phase 2 study of VX-809 and KALYDECO showed significant improvements in lung function among adults with cystic fibrosis.</description><link>http://www.rttnews.com/story.aspx?Id=1878946</link><pubDate>Mon, 07 May 2012 13:36:47 GMT</pubDate></item></channel></rss>

